Skip to content
Search

Latest Stories

Primary Care recovery plan negotiations to be announced in ‘few weeks’, says CPE chief

Negotiations around the £645 million investment pledged to community pharmacies have concluded, confirmed Janet Morrison

Community Pharmacy England (CPE) CEO, Janet Morrison said that the negotiations for the £645 million investment pledged to community pharmacies in 2023-25 have concluded.


The government's primary care recovery plan is to be announced in a “few weeks” and negotiations for the Community Pharmacy Contractual Framework (CPCF) from April 2024 will begin.

She said: “We have finished the substantive discussions on the recovery plan but detailed discussions about implementation are ongoing and we are awaiting final clearance from the Government and the NHS.

“We hope that we will be in a position to make an announcement in the next few weeks and that negotiations on the CPCF from April 2024 will commence soon after that.”

Morrison reminded attendees that the Primary Care Recovery Plan is “to improve access to primary care by investing £645 million over the remainder of the year”.

She said that by next year, this support service would be called “Pharmacy First” – a walk-in service combined with CPCS and 111 referrals.

The service would cover seven conditions - sinusitis, sore throat, earache, infected insect bit, impetigo, shingles and uncomplicated UTI in women.

The recovery plan is also an expansion of the “NHS Pharmacy Contraception Service” and the “NHS Community Pharmacy Blood Pressure Checks Service” with supporting improvements to the digital infrastructure.

“It's a very significant investment in the digital infrastructure to enable community pharmacy to access patient records, update them and refer back to GPS,” she said.

Morrison gave an insight into the negotiations to the 260 delegates present at the 2023 Sigma conference.

She said: “The negotiations have been more complex than usual, because of the courage of government stakeholders on the government side which has led to delays.

“It's had to have really high-level approval through Number 10 and the Treasury at a level,” and some “very significant work programmes has been the clinical pathways, led by NHS England reporting into the chief medical officer, and digital development including IT providers to both community pharmacy and general practice.”

“It is a complex and critical part of delivering this service,” Morrison added.

The CPE chief confirmed that the one-year community pharmacy contractual framework (CPCF) 2024-2025 will begin immediately.

Moreover, she laid the groundwork for the next CPCF that will “enable the evolution of the CPCF and of community pharmacy as a valued part of integrated primary care that delivers solutions for patients.”

Plan for future sustainability, vision and strategic project options with the King’s Field and Nuffield Trust shared with NHS England and the Department of Health and Social Care (DHSC).

“The spending review has another year to run, and we are waiting for the department and for NHS England to get their mandate, which is what they're approved to be able to stand by the government.

“We’ve been asking for an uplift to the baseline contract - we're currently doing a review of fees, new funding for increased volumes of the existing services,” she concluded.

She also highlighted CPE’s vision, from preventing ill health to supporting well-being, providing clinical care, living well with medicines and ensuring community pharmacy as part of an integrated primary care offer.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less